Targeting Trojan Horse leukocytes for HIV prevention.
Anderson
Deborah J
DJ
Department of Obstetrics and Gynecology, Boston University, School of Medicine, Boston, MA, USA. Deborah.Anderson@BMC.org
Politch
Joseph A
JA
Nadolski
Adam M
AM
Blaskewicz
Caitlin D
CD
Pudney
Jeffrey
J
Mayer
Kenneth H
KH
D000818:Animals; D002448:Cell Adhesion; D002465:Cell Movement; D002584:Cervix Uteri / Q000378:metabolism / Q000821:virology; D005260:Female; D005835:Genitalia / Q000276:immunology / Q000821:virology*; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission*; D015497:HIV-1; D006801:Humans; D016089:Immunodeficiency Virus, Feline; D007958:Leukocyte Count; D007962:Leukocytes / Q000276:immunology / Q000821:virology*; D008297:Male; D009092:Mucous Membrane / Q000276:immunology / Q000821:virology; D012661:Semen / Q000166:cytology / Q000821:virology*; D014621:Vagina / Q000378:metabolism / Q000821:virology